Valencia Technologies Announces Strategic Investment and Appoints Jim Surek as Chief Executive Officer
Company Positioned for Accelerated Growth with Infusion of Capital and Proven Commercial Leadership - PRNewsWire VALENCIA, [...]
CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure
VALENCIA, Calif., July 11, 2024 /PRNewswire/ -- Valencia Technologies Corporation announced today that the Department of [...]
Implantable Tibial Nerve Stimulation added as Treatment Option within AUA/SUFU 2024 OAB Guideline
VALENCIA, Calif., May 2, 2024 /PRNewswire/ -- Valencia Technologies is pleased to announce that implantable tibial nerve stimulation [...]
Anthem Blue Cross and Blue Shield Announces Coverage for the eCoin System for Urinary Incontinence
VALENCIA, Calif., Jan. 9, 2024 /PRNewswire/ --Valencia Technologies Corporation announced today that Anthem Blue Cross and Blue Shield [...]
CMS has confirmed that new Category III CPT code 0816T for reporting the eCoin
VALENCIA, Calif., Nov. 7, 2023 /PRNewswire/ -- As outlined in the 2024 Medicare Program: HOPPS [...]
CMS Recognizes eCoin System Coding and Payment in 2024
VALENCIA, Calif., July 17, 2023 /PRNewswire/ -- Valencia Technologies Corporation announced today that the Department of Health and [...]
CMS Confirms CPT Code 64590 for eCoin
Valencia Technologies Corporation announced today that the Centers for Medicare & Medicaid Services (CMS), Division [...]
Valencia Technologies Announces First Commercial Implantation of eCoin®
Valencia Technologies Announces First Commercial Implantation of eCoin® Leadless Tibial Neurostimulator for the Treatment of [...]
Valencia Technologies Retains PRIA Healthcare
VALENCIA, Calif., May 10, 2022 /PRNewswire/ -- Valencia Technologies Corporation ("Valencia" or the "Company"), a privately held company, [...]
eCoin® featured in Urology Times Journal
Consistent procedure performed using only local anesthetic. Revolutionary leadless design. Automatic therapy with no patient device [...]